Novo Nordisk, the Danish pharmaceutical giant that makes the blockbuster Wegovy obesity drug, said it will invest over $6 billion to boost production capacity.
Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity
